Waters Corporation (WAT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

34 MAPLE ST MILFORD, MA 01757

Waters Corporation (Waters) is an analytical instrument manufacturer. Through its Waters Division, Waters designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC), referred to as liquid chromatography (LC), and mass spectrometry (MS) instrument systems and support products, including chromatography columns and other consumable products, and post-warranty service plans. Through its TA Division (TA), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments. The Company is also a developer and supplier of software-based products that interface with the Company's instruments, as well as other manufacturers' instruments.

Data as of 2020-08-09
Market Cap13.149 Billion Shares Outstanding61.926 Million Avg 30-day Volume668.553 Thousand
P/E Ratio26.6 Dividend Yield EPS7.97
Price/Sales5.771 Price cash flow ratio19.6 Price free cash flow ratio31.4
Book Value-3.1 Price to Tangible Book-15.15 Alpha0.0
Short Interest Ratio3.69 % Short Interest to Float5.1 R-squared0.373576
BETA1.03548 52-week High/Low245.68 / 154.39 Stddev0.071241
View SEC Filings from WAT instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 6 1 (0.07%)
13F Filers holding this stock: 510 101 (6.61%)
Aggregate 13F shares on 03/31/2020: 58.554 Million 24.019 Million
Aggregate 13F shares on 12/31/2019: 61.788 Million 24.676 Million
Percent change: -5.24% -2.66%
Funds creating new positions: 47 16
Funds Adding to an existing position: 154 28
Funds closing out their position: 93 24
Funds reducing their position: 221 39
Heat Map Ranking for 03/31/2020 375
Heat Map Ranking for 12/31/2019 371
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding WAT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding WAT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

30.2 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

30 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SALICE THOMAS P

  • Director
62,694 2020-08-07 3

ALEMAN KEELEY A SVP GENERAL COUNSEL & CORP SEC

  • Officer
1,385 2020-08-05 9

OCONNELL CHRISTOPHER J CEO AND PRESIDENT

  • Officer
27,595 2020-07-31 3

BUCK SHERRY

  • Director
556 2020-07-15 3

WELCH DANIEL J. SVP GLOBAL OPERATIONS

  • Officer
2,600 2020-07-09 2

HENDRICKSON GARY E

  • Director
31,277 2020-07-01 4

CONARD EDWARD

  • Director
67,865 2020-06-30 5

BEKENSTEIN JOSHUA

  • Director
5,747 2020-06-16 0

REED JOANN A

  • Director
48,060 2020-06-08 2

RAE ELIZABETH B SVP, GLOBAL HR

  • Officer
13,767 2020-05-18 4

SILVEIRA MICHAEL F VP, CORPORATE CONTROLLER

  • Officer
1,557 2020-03-02 2

KING IAN SVP, GLOBAL PRODUCTS

  • Officer
5,200 2020-03-02 4

HARRINGTON MICHAEL C SVP, GLOBAL MARKETS

  • Officer
2,286 2020-03-02 3

KIM FRANCIS SVP GLOBAL OPERATIONS

  • Officer
2,952 2020-03-02 4

CARSON ROBERT G SVP CORPORATE DEVELOPMENT

  • Officer
1,174 2020-02-12 1

PRATT JONATHAN M SVP, PRESIDENT TA INSTRUMENTS

  • Officer
1,217 2020-02-12 3

ORNELL JOHN A

  • Director
14,657 2020-01-06 0

BERENDT MICHAEL J

  • Director
21,977 2020-01-02 1

GLIMCHER LAURIE H M.D.

  • Director
4,067 2020-01-02 2

KUEBLER CHRISTOPHER A

  • Director
15,977 2020-01-02 1

BADDOUR LINDA

  • Director
1,358 2020-01-02 1

ORNSKOV FLEMMING

  • Director
2,222 2019-12-31 2

BEAUDOUIN MARK T SVP AND GENERAL COUNSEL

  • Officer
5,862 2019-11-15 2

KELLY TERRENCE P SVP, PRESIDENT TA INSTRUMENTS

  • Officer
0 2019-03-11 0

TERRICCIANO DAVID SVP, GLOBAL OPERATIONS

  • Officer
3,173 2018-02-28 0

CASSIS EUGENE G SVP

  • Officer
17,596 2018-02-14 0

KHANNA ROHIT SVP, APPLIED TECHNOLOGY

  • Officer
No longer subject to file 2017-12-29 0

MILLER WILLIAM J

  • Director
22,349 2017-12-05 0

BERTHIAUME DOUGLAS A

  • Director
3,067,109 2017-11-03 0

CAPUTO ARTHUR G EVP AND PRESIDENT, WATERS DIV

  • Officer
85,217 2016-12-06 0

CURRY WILLIAM VP, CORP CONT & PRIN ACCT OFF

  • Officer
978 2013-06-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ALEMAN KEELEY A - Officer SVP GENERAL COUNSEL & CORP SEC

2020-08-05 S 150 $210.47 d 1,253 1,385.00 direct

OCONNELL CHRISTOPHER J - Officer CEO AND PRESIDENT

2020-07-31 S 30,000 $213.30 d 27,595 27,595.00 direct

OCONNELL CHRISTOPHER J - Officer CEO AND PRESIDENT

2020-07-31 M 30,000 $123.55 a 57,595 27,595.00 direct

OCONNELL CHRISTOPHER J - Officer CEO AND PRESIDENT

2020-07-31 M 30,000 d 47,826 27,595.00 direct

WELCH DANIEL J. - Officer SVP GLOBAL OPERATIONS

2020-07-09 A 1,060 a 3,069 3,659.66 direct

WELCH DANIEL J. - Officer SVP GLOBAL OPERATIONS

2020-07-09 A 2,865 a 2,865 3,659.66 direct

CONARD EDWARD - Director

2020-06-30 A 142 a 142 67,865.00 direct

HENDRICKSON GARY E - Director

2020-06-30 A 137 a 137 1,358.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments